Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 539

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1
Chunk 539
---
 has the following wholly owned subsidiaries:

    -
    NeuroNOS Ltd Israel, incorporated on March 12, 2024

    -
    NNOS U.S., Inc, incorporated in Delaware on January 10, 2025

    -
    Beyond Air Cyprus Limited, incorporated on October 13, 2021 in Cyprus.

    We have 80% ownership in the following entity:

    -
    Beyond Air Bermuda Limited, incorporated on August 13, 2021 in Bermuda. In September 2022, its name was changed to Beyond Cancer Bermuda Limited.

    Beyond Air Bermuda Limited has the following wholly owned subsidiaries:

    -
    XAIR Israel Ltd, incorporated on October 3, 2021 in Israel.

    -
    Beyond Cancer U.S., Inc., incorporated on March 17, 2022 in Delaware.

On August 8, 2024, we received
a letter from the Nasdaq Listing Qualifications Department notifying us that, for the 30 consecutive business day period between June
25, 2024 through August 7, 2024, our common stock had not maintained a minimum closing bid price of $1.00 per share required for continued
listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq
Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until February 4, 2025 (the “Compliance
Period”), to regain compliance with the Bid Price Rule. In order to regain compliance with the Bid Price Rule, our common stock
was required to maintain a minimum closing bid price of $1.00 for a minimum of ten consecutive business days during the Compliance Period
prior to February 4, 2025.

As of February 4, 2025, the common
stock has not regained compliance with the Bid Price Rule. However, in a letter dated February 5, 2025 (the “Second Nasdaq Bid Price
Letter”), Nasdaq notified the Company that Nasdaq’s Staff has determined that the Company is eligible for an additional 180
calendar day period, or until August 4, 2025, to regain compliance (the “Second Compliance Period”). As of the date of this
report the common stock has not regained compliance with the Bid Price Rule. If the Company chooses to implement a reverse stock split,
it must complete the split no later